PMC:7463108 / 83944-84061 JSONTXT

{"project":"LitCovid-PD-FMA-UBERON","denotations":[{"id":"T807","span":{"begin":89,"end":92},"obj":"Body_part"},{"id":"T808","span":{"begin":102,"end":112},"obj":"Body_part"}],"attributes":[{"id":"A807","pred":"fma_id","subj":"T807","obj":"http://purl.org/sig/ont/fma/fma278683"},{"id":"A808","pred":"fma_id","subj":"T808","obj":"http://purl.org/sig/ont/fma/fma54537"}],"text":"ve with opiate co-exposure. Importantly, unlike maraviroc, the bivalent compound blocked HIV entry in astrocytes irre"}

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T869","span":{"begin":102,"end":112},"obj":"http://purl.obolibrary.org/obo/CL_0000127"}],"text":"ve with opiate co-exposure. Importantly, unlike maraviroc, the bivalent compound blocked HIV entry in astrocytes irre"}

{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T3651","span":{"begin":48,"end":57},"obj":"Chemical"}],"attributes":[{"id":"A47154","pred":"chebi_id","subj":"T3651","obj":"http://purl.obolibrary.org/obo/CHEBI_63608"}],"text":"ve with opiate co-exposure. Importantly, unlike maraviroc, the bivalent compound blocked HIV entry in astrocytes irre"}

{"project":"LitCovid-PubTator","denotations":[{"id":"2951","span":{"begin":89,"end":92},"obj":"Species"}],"attributes":[{"id":"A2951","pred":"tao:has_database_id","subj":"2951","obj":"Tax:12721"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"ve with opiate co-exposure. Importantly, unlike maraviroc, the bivalent compound blocked HIV entry in astrocytes irre"}